JAC Advance Access originally published online on February 27, 2009
Journal of Antimicrobial Chemotherapy 2009 63(5):1071-1073; doi:10.1093/jac/dkp052
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Research letters |
Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain
1 Service de Bactériologie-Virologie, INSERM U914, Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine et Université Paris Sud, Bicêtre, France 2 College of Medecine, Arabian Gulf University and Salmaniya Medical Complex, Kingdom of Bahrain
* Corresponding author. Service de Bactériologie-Virologie, Hôpital de Bicêtre, 76 rue du général Leclerc, 94275 Le Kremlin-Bicêtre cedex, France. Tel: +33-1-45-21-36-24; Fax: +33-1-45-21-63-40; E-mail: nordmann.patrice@bct.aphp.fr
Keywords: A. baumannii , Middle East , resistance , β-lactamases
| The first 10% of the full text of this article appears below. |
Sir,
Carbapenem resistance in Acinetobacter baumannii is now increasingly reported. The most prevalent mechanism of carbapenem resistance in A. baumannii corresponds to the production of acquired carbapenem-hydrolysing class D β-lactamases (CHDLs)1 encoded by blaOXA-23-like, blaOXA-40-like or blaOXA-58-like genes. Whereas the blaOXA-40 gene has been detected in Portugal, Spain and the USA, blaOXA-23 and blaOXA-58 genes have disseminated worldwide.1
The aim of our study was to identify the molecular mechanisms leading to carbapenem resistance among a panel of A. baumannii isolates exhibiting resistance or intermediate susceptibility to imipenem and collected from September 2007 to March 2008
| Funding |
|---|
| Transparency declarations |
|---|